TestGrid Wins ‘Best Use of AI’ at India Digital Enabler Awards 2026, Powered by Entrepreneur India
Recognition from one of India's most prominent technology award platforms underscores a…
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
ADAPT OCULUS is the first study to evaluate a targeted treatment for…
“Responsible” Use of AI in Education is a Range, Turnitin Finds in First Learning Integrity Insights Report
Turnitin's report shows a consistent percentage of "traditional" plagiarism, even in the…
IMG Travel Outlook Survey Reveals 2026 Top Destinations and Rising Use of AI in Trip Planning
INDIANAPOLIS, March 24, 2026 /PRNewswire/ -- IMG has released the results of…
Zocdoc Launches The AI-Informed Patient Report, Revealing How Patient Use of AI Is Reshaping the Patient-Provider Relationship
New findings highlight rising—yet hidden—patient use of AI and surprisingly optimistic providers,…
Government of Andhra Pradesh Partners with Calibo to Advance Business Innovation with Bite Size Use Case Leveraging Data and AI
This includes establishing the Calibo AI Academy to embed AI-integrated learning across…
iFLYTEK Debuts AI Glasses and New AI Devices at MWC26, Advancing AI for Use, AI for Trust
Barcelona, March 04, 2026 (GLOBE NEWSWIRE) -- iFLYTEK held a global launch…
FDA 510(k) Clearance Establishes Broad Intended Use for Copan’s PhenoMATRIX, Expanding Clinical Microbiology Capabilities
MURRIETA, Calif., Feb. 17, 2026 /PRNewswire/ -- Copan Group announced today that…
New BrowserStack Report Finds 94% of Teams Use AI in Testing, but Only 12% Have Reached Full Autonomy
DUBLIN, Feb. 10, 2026 /PRNewswire/ -- BrowserStack today released its State of AI…
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet in the treatment of canine mast cell tumors
PRESS RELEASE AB SCIENCE ANNOUNCES THAT THE FDA HAS GRANTED THE STATUS…
